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Classically, geneticists are accustomed to thinking of then, arises not solely because of a defect in a protein
structure but, rather, because the machinery that dis-missense mutations as relatively benign, or at least less
hazardous than clear null alleles such as large genomic poses of aberrantly folded proteins is for some reason
not equal to the task.deletions or nonsense mutations. At the cellular level,
however, the opposite is often the case; missense mu-
tants that are synthesized but fail to mature along the The Ubiquitin-Mediated Degradation Pathway and Its
normal folding pathway may prove more troublesome Targets
than simple loss of expression.
Protein degradation, the ﬁnal stage in cellular regula-Cells possess a robust machinery to degrade mRNAs
tion of gene expression, represents the last chance for athat, as a consequence of genetic lesions or errors in
cell to suppress the potentially toxic effects of expressionRNA processing, display premature-termination co-
of aberrant proteins. One pathway that helps clear mis-dons. The cues by which inappropriate breaks in open
folded proteins is the degradative mechanism used inreading frames (ORFs) are recognized are uncertain
the turnover of naturally short-lived cytoplasmic pro-(Maquat 1996)—even the subcellular location of non-
teins, the ubiquitin/proteasome pathway (Finley andsense-mediated decay is controversial—but the conse-
Chau 1991), in which proteins are targeted for degrada-quence is unambiguous: thanks to this monitoring pro-
tion by covalent modiﬁcation. Ubiquitin, a small andcess, many prematurely terminating alleles become true
highly conserved protein, is conjugated onto a lysinenulls. Experience with genetically altered mice conﬁrms
residue of a target protein by a ubiquitin-conjugatingthe wisdom of this regulatory strategy. Transgenic ani-
enzyme (UBC). Subsequently, more ubiquitin proteinsmals that express genes either ectopically or with abnor-
are conjugated to the ubiquitin adduct, and this processmal sequences are often manifestly sick. On the other
can continue indeﬁnitely to form a polyubiquitin chain.hand, gene targeting, which typically creates null alleles
Polyubiquitinated proteins are recognized and rapidlyof the gene of interest, often leads to normal or nearly
degraded by a large multisubunit complex of protein-normal phenotypes, probably because of functional re-
ases, the 26S proteasome. Protein species that aredundancy within the genome (Wang et al. 1996). In mice
marked for degradation can be identiﬁed on protein gelsas well as humans, lack of gene expression may be more
by their ‘‘ladder’’ of more slowly migrating polyubiquiti-benign than abnormal gene expression.
nated forms. Because the proteasome will degrade mostNo general mechanism exists, at the nucleic-acid level,
polyubiquitinated species, a crucial step in controllingto convert missense mutations to null alleles, but the cell
protein turnover is the initial recognition of a target byis far from helpless to restrict the expression of abnormal
a UBC. The determinants for this recognition have beenproteins. The machinery that assists the folding of na-
deﬁned in certain proteins that, in their wild-type form,scent proteins to their ﬁnal native conformation also
degrade rapidly. In some cases, the exposed N-terminalidentiﬁes unfolded or misfolded polypeptides. When
residue plays a key role in determining protein longevitythings go right, this same system leads to the efﬁcient
(Varshavsky 1992); in other cases, larger domains areremoval of these abnormal proteins. Genetic disease,
required for rapid turnover (Rechtsteiner and Rogers
1996). The destabilizing determinants in misfolded pro-
teins are not known, but the events downstream of UBCAddress for correspondence and reprints: Dr. John Ashkenas, Amer-
appear to be the same for both normal and misfoldedican Journal of Human Genetics, University of Wahington, Box
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doplasmic reticulum (ER) proteins must occur through HSP homologues probably operate on their protein sub-
strates by common mechanisms.an endogenous ER proteolytic pathway distinct from
the lysosomal or proteosomal pathways. This view has Protein Folding in the Secretory Pathway
shifted (Kopito 1997) with reports that degradation of
Many of the resident proteins of the ER assist in theER-membrane proteins and even ER-lumenal proteins
maturation of secretory proteins destined for other com-can be inhibited when the ubiquitin/proteasome path-
partments or for the extracellular space. They mediateway is compromised. Thus, in yeast, mutations that af-
insertion through the ER membrane (Rapoport et al.fect ubiquitin, UBC enzymes, or subunits of the 26S
1996), they carry out posttranslational modiﬁcationsproteasome block degradation of secretory proteins
such as glycosylation, proteolytic trimming, and disul-(Hiller et al. 1996). Similarly, in mammalian cells, degra-
ﬁde bond formation, and they assist in folding and as-dation of ER-associated secretory (Qu et al. 1996) or
sembly of secreted and integral membrane proteinstransmembrane (Jensen et al. 1995; Ward et al. 1995)
(Hebert et al. 1995a, 1995b). Three of the major chaper-proteins requires polyubiquitination and is sensitive to
ones of the ER are BiP, a member of the Hsp70 family;lactacystin, a proteasome inhibitor that is not known
calreticulin, a lumenal protein; and calnexin, a trans-to inhibit any other proteinases. The process by which
membrane protein. The last two proteins behave aslumenal components are ‘‘delocated’’ (Kopito 1997)
lectins—they bind to sugar moieties on nascent glyco-back to the cytoplasm from the ER remains unexplained,
proteins (Ware et al. 1995)—but it appears that theybut chaperone proteins, as described below, may partici-
can also bind to nascent proteins that lack carbohydratespate (Qu et al. 1996).
(Kim and Arvan 1995).
The induction of the ER-resident HSPs is regulated,
Components of the Protein-Folding Machinery along with cytoplasmic and mitochondrial HSPs, by the
transcriptional activator, heat-shock factor, but recentThe heat-shock response (Leppa and Sistonen 1997)
work has identiﬁed in yeast an independent pathwayprovided the ﬁrst glimpse of a cellular machinery that
that speciﬁcally induces ER-resident chaperones whencould discriminate between native and non-native pro-
unfolded proteins accumulate in this organelle. This un-tein conformations. Heat shock–induced proteins
folded-protein response (UPR) pathway (ﬁg. 1) is medi-(HSPs) mediate protein refolding to the native confor-
ated by an ER-resident transmembrane receptor kinasemation after heat or some other environmental shock
protein Ire1p, which directly or indirectly senses thecauses a cell to accumulate unfolded protein. HSPs,
presence of unfolded protein in the ER lumen. Ire1pwhich fall into several families, use ATP energy to drive
then transduces a signal that activates transcription ofthe refolding process. In addition to heat, such condi-
the yeast BiP homologue by altering the pattern of splic-tions as ischemia (Kuznetsov et al. 1996) or proteasome
ing of the mRNA encoding the transcription factor
inhibition (Bush et al. 1997) cause the various HSPs to
Hac1p (Cox and Walter 1996). This alternative splicing
be induced in concert, and they result in cells becoming
event (Sidrauski et al. 1996), which is novel and mecha-
tolerant to similar, more severe treatments. nistically unrelated to the process discussed by Cooper
Even without stress to induce them, HSPs and other and Mattox (1997 [in this issue]), causes a change in
classes of molecular chaperones are expressed in healthy the 3’ end of the Hac1p ORF. Although both the in-
cells, where they act in protein biosynthesis to stabilize duced and the uninduced spliced forms of Hac1 mRNA
nascent protein chains and to unfold and refold proteins encode active transcription factors, the uninduced pro-
as they cross from the cytoplasm into membrane- tein is efﬁciently degraded, probably by the ubiquitin/
bounded organelles. There is considerable evidence for proteasome pathway (Cox andWalter 1996). Activation
specialization among chaperones, in their subcellular of Ire1p by unfolded proteins in the ER also activates
distribution, in their preferred substrates, and in their another transcription factor, Gcn5p, which interacts di-
mode of interaction with substrates. Hsp104, for exam- rectly with Ire1p. Welihinda et al. (1997) argue that
ple, a chaperone in the yeast cytoplasm, serves to solubi- Gcn5p and Hac1p form part of a large transactivator
lize proteins from heat shock–induced protein aggre- complex that induces ER chaperones but not cyto-
gates but not to prevent aggregation (Parsell et al. 1994). plasmic heat-shock proteins. The UPR pathway has so
Likewise, Lhs1p, an Hsp70 homologue found in the far only been demonstrated in yeast, but it will be of
yeast ER, appears not to be involved in biosynthetic great interest to learn to what extent it is conserved in
folding pathways in the secretory pathway but, rather, human cells.
to permit disaggregation and refolding of several pro-
Chaperones as Defense Attorney, Judge, andteins after heat-induced denaturation (Saris et al. 1997).
ExecutionerHsp47, several groups have argued, speciﬁcally mediates
the folding of collagen triple helices in the ER (Nagata Chaperones are present at millimolar levels in the ER
lumen, in considerable excess over substrates, and, in1996). Despite their functional diversity, the various
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leagues have proposed a simple model based on sequen-
tial rounds of glucosylation and deglucolsylation of
N-linked sugars on glycoproteins (ﬁg. 2) (Hammond
and Helenius 1995; Hebert et al. 1995a, 1995b).
N-linked oligosaccharides are added cotranslationally
to proteins as they enter the ER, and they are trimmed by
glucosidases to the monoglucosylated form. This sugar
structure mediates binding to calnexin and/or calreti-
culin, and, according to the model, the protein will re-
main bound until released in deglucosylated form by a
glucosidase. The key quality-control step, the readdition
of a glucose, is then mediated by a glucosyltransferase
that acts speciﬁcally on unfolded glycoproteins. The re-
glucosylated protein is then once again retained on cal-
nexin or calreticulin; folded glycoproteins, which cannot
be reglucosylated, are free to leave the ER and continueFigure 1 UPR. Two pathways in the transcriptional induction
to move through the secretory pathway. This mecha-of ER chaperones have been described. The transmembrane protein
nism may apply generally to nascent secretory proteinsIre1p signals the presence of accumulated unfolded proteins in the
ER. Activated Ire1p, shown here bound to a cloud of unfolded protein with N-linked carbohydrates and may provide a basis
at its lumenal aspect, transmits a signal that results in the alternative for understanding other classes of quality-control
splicing of the Hac1 mRNA. As a result, the induced form of the Hac1 events.
protein is synthesized, and this protein binds to the UPR element
Such a mechanism can be extended to explain the(UPRE) in the promoter of various ER chaperone genes (Cox and
turnover of misfolded proteins that are retained by chap-Walter 1996). A second pathway, which may be independent of the
ﬁrst, involves the activation of the Gcn5 protein. This protein binds erones. A simple model suggests that proteins bound to
directly to Ire1p and participates in a complex of DNA-binding pro- chaperones are safe from proteolysis (as are most prop-
teins that activates transcription of the yeast BiP homologue (Weli- erly folded proteins) and that rounds of binding and
hinda et al. 1997). Most likely, Gcn5p is released from Ire1p as this
release from chaperones work toward protein matura-receptor is activated by unfolded proteins. Ire1p is shown here signal-
tion (Farr et al. 1997). Folded proteins in the ER areing directly into the nucleoplasm, but it is also possible that it faces
the cytoplasm and that the activated signaling molecules need to pass released to traverse the secretory pathway, but retained
into the nucleus to act as transcriptional regulators. unfolded proteins are captured by the degradative ma-
addition to interacting with nascent secretory proteins,
they participate in numerous weak interactions with
other ER-resident proteins (Hammond and Helenius
1995; Hebert et al. 1995b). These interactions are pre-
sumed to give the ER lumen some viscosity and internal
structure (Kuznetsov et al. 1997): Helenius and col-
leagues compare it to a mixed-bed afﬁnity-chromatogra-
Figure 2 Model for the selective retention of unfolded glyoprot-phy resin through which a secretory protein needs to
eins in the ER (Hebert et al. 1995b). As a nascent protein (curvedpass as it interacts with the different resident proteins
line) is extruded across the ER membrane (shaded bar), an oligosac-at different stages of the maturation pathway. Indeed,
charide chain (shown here above the curve of the protein) is added
Kim and Arvan (1995) have shown that the folding cotranslationally. A newly synthesized glycoprotein is then released in
pathway of one secreted glycoprotein, thyroglobulin, unfolded form and, in step A, its oligosaccharide chain is enzymatically
trimmed by glucosidases that remove terminal glucose units (triangles).proceeds through intermediate stages, ﬁrst interacting
Once the oligosaccharide has been trimmed to the monoglucoslylatedwith calnexin and later dissociating from it and bind-
form, chaperone proteins (shaded ﬁgure), such as calnexin or calreti-ing BiP.
culin, may bind the glycoprotein. The glycoprotein may be released
To generate a quality-control system from the interac- from the chaperone if the ﬁnal glucose is removed by a glucosidase
tions between the nascent protein and the chaperones, (step B, rightward-pointing arrow), but a speciﬁc glucosyltransferase,
acting on the unfolded protein, can replace the lost glucose unit sothere needs to be at least one step in which chaperones
that the monoglucosylated protein can bind the chaperone once againor other proteins distinguish between properly and im-
(step B, leftward-pointing arrow). However, once the protein is folded,properly folded proteins, release the mature protein, and
this process becomes irreversible: the glucosidase can act on the folded
either retain the unfolded forms or target them for deg- glycoprotein and release it (step C, rightward-pointing arrow), but
radation. Although this crucial recognition step is not the glucosyltransferase cannot act on the folded protein, and the folded
glycoprotein is free to continue through the secretory pathway.fully understood in any instance, Helenius and col-
/ 9a30$$au40 08-01-97 10:55:57 ajhga UC-AJHG
270 Am. J. Hum. Genet. 61:267–272, 1997
chinery. Such capture could be a purely passive and Although the role of chaperones in cystic ﬁbrosis re-
mains speculative, the spectrum of symptoms in anotherstochastic process, but it appears that, at least in some
cases, chaperones play an active role in protein degrada- heritable disorder, a1-antitrypsin (a1-AT) deﬁciency,
appears to reﬂect variability in the cell’s response totion. Hayes and Dice (1996) cite evidence that the
Hsp70 homologue Hsc73 is required on both the cyto- abnormal proteins. Even as part of its normal folding
pathway (Ou et al. 1993; Wu et al. 1994), a1-AT inter-plasmic side and the lumenal side of lysosomes in order
to get efﬁcient import of certain cytosolic proteins into acts with the transmembrane ER chaperone calnexin,
but only the mutant protein accumulates in the ER andthis degradative organelle. In vitro, Hsc73 also mediates
the degradation of unfolded protein by the cytoplasmic- is degraded by the proteasome. In this degradative path-
way, calnexin itself is polyubiquitinated, presumably onubiquitin/proteasome pathway. Furthermore, as dis-
cussed below, the transmembrane ER chaperone cal- its cytoplasmic face (Qu et al. 1996). This ﬁnding sug-
gest that the binding of mutant a1-AT to calnexin causesnexin serves both to retain nascent glycoproteins and to
target their abnormal variants for destruction. a conformational change in the chaperone, which is rec-
ognized by cytoplasmic UBCs. The ubiquitination of cal-
nexin appears to mark the whole complex for transportMutant Proteins in Human Disease
from the ER and for degradation by the proteasome.
Mutations in the a1-AT gene have distinct conse-Human genetic disorders, whether dominantly or re-
cessively inherited, commonly arise from sequence quences for liver—which expresses this proteinase in-
hibitor—and for other tissues that are affected by itschanges that alter protein function, such as enzymatic
activity or structural or regulatory interactions. To the absence (Wu et al. 1994; Teckman et al. 1996). Loss of
secreted a1-AT, as seen in people homozygous for theextent that the cell can recognize an altered protein, the
protein can be redirected to the degradative pathway, missense PiZ or PiS alleles, alters the balance of elastase
and inhibitors in the lung and so predisposes to emphy-and the cell can be spared the consequences of accumu-
lating the abnormal protein. sema. Whereas PiS homozygotes are free of severe liver
symptoms, a subset of PiZ-homozygous individuals, de-In the case of the cystic ﬁbrosis transmembrane con-
ductance regulator (CFTR), a multipass integral mem- scribed as ‘‘susceptible hosts,’’ develop cirrhosis and
other liver disorders as abnormal protein accumulatesbrane protein, it has been shown that a number of subtle
mutations, including the common disease allele DF508, in the distended ER of hepatocytes Other individuals
with the PiZ-homozygous genotype, ‘‘protected hosts,’’cause CFTR to persist in the ER (Cheng et al. 1990). In
fact, Ç75% of all wild-type CFTR protein fails to exit degrade the mutant protein efﬁciently, and their liver
cells are morphologically normal. Wu et al. (1994) ex-the ER but accumulates there and eventually is degraded
by the ubiquitin/proteasome pathway (Jensen et al. pressed normal and PiZ a1-AT proteins in ﬁbroblasts
from protected and susceptible individuals and observed1995; Ward et al. 1995). This inefﬁcient maturation is
not an artifact of overexpression, since it is observed this difference in efﬁciency of degradation in these cells
as well. Furthermore, the two mutant a1-AT alleles be-even in cells that express the protein at moderate levels;
rather, it probably reﬂects the action of competing path- haved consistently in the cell-culture system: Whether
the cells used are from individuals susceptible to or pro-ways for retention and for maturation of the protein.
The DF508 mutation evidently tips the balance so that tected from liver disease, both classes of abnormal pro-
teins are retained in the ER. When expressed in suscepti-the protein is retained quantitatively, but, despite its
different fate in biosynthesis, this mutation does not ble cells, there is a lag in the degradation of the retained
protein, and the more extreme lag was associated withgrossly perturb the structure of the protein or alter its
activity as an ion channel. When assayed in the ER, the more severe PiZ allele (Teckman and Perlmutter
1996). Teckman et al. (1996) have begun to deﬁne thewild-type and DF508 CFTR act as chloride channels
with indistinguishable kinetic properties (Pasyk and biochemical features associated with susceptibility. In
cells from one susceptible host, they ﬁnd that abnormalFoskett 1995), indicating that the mutant protein folds
to a close approximation of its native conformation. a1-AT interacts poorly with calnexin; in other suscepti-
ble hosts, the protein is degraded poorly even thoughHence, at least for those who are homozygous for this
common mutant allele, cystic ﬁbrosis appears to be not its interaction with calnexin is efﬁcient. These results
strongly suggest that the susceptibility phenotype reﬂectsso much a disorder of the CFTR as of the protein-matu-
ration machinery that fails to release it as a functional genetic differences in the proteolysis of the mutant pro-
teins, possibly in the interaction between the mutantprotein to the cell surface. This raises the possibility that
differences in chaperone function could modulate the protein and calnexin.
Like a1-AT, collagens are secreted through the ER,severity of the symptoms of the disease, and it may ex-
plain the rare individuals homozygous for this allele who and, in some cases, mutations cause massive accumula-
tion that is apparent by examination of affected tissuesare only minimally symptomatic.
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ulum chaperones, and thermotolerance. J Biol Chem 272:(e.g., see Smith et al. 1997). It is likely that mutations
9086–9092in different functional domains of collagen-precursor
Cheng S, Gregory R, Marshall J, Paul S, Souza D, White G,chains activate an array of cellular strategies to mitigate
O’Riordan C, et al (1990) Defective intracellular transportthe damage that could result if these molecules were
and processing of CFTR is the molecular basis of most cysticsecreted. Mutations in the carboxyl-terminal propep-
ﬁbrosis. Cell 63:827–834
tide—the domain through which the initial chain-chain Chessler SD, Byers PH (1992) Defective folding and stable
interactions occur—interfere with but do not abolish association with protein disulﬁde isomerase/prolyl hydroxy-
assembly of collagen trimers. Such mutations induce lase of type I procollagen with a deletion in the proa2(I)
BiP, possibly through the UPR pathway, and lead to chain that preserves the Gly-X-Y repeat pattern. J Biol Chem
moderately efﬁcient degradation of the abnormal pro- 267:7751–7757
(1993) BiP binds type I procollagen proa chains withteins (Chessler and Byers 1993; Chessler et al. 1993).
mutations in the carboxyl-terminal propeptide synthesizedHowever, mutations in the triple-helical domain that
by cells from patients with osteogenesis imperfecta. J Biolinterfere with helix propagation result in ER retention
Chem 268:18226–18233with very slow degradation and do not activate the UPR,
Chessler SD, Wallis GA, Byers PH (1993) Mutations in theeven though the triple helix of these molecules is not
carboxyl-terminal propeptide of the proa1(I) chain of type‘‘folded’’ at the normal temperatures (Chessler and By-
I collagen result in defective chain association and produce
ers 1992). Instead, retention is mediated by interaction lethal osteogenesis imperfecta. J Biol Chem 268:18218–
with the ER-resident protein, prolyl hydroxylase, which 18225
binds nonfolded helical structures that are substrates Cox J, Walter P (1996) A novel mechansim for regulating
for hydroxylation. The mechanism by which the slow activity of a transcripiton factor that controls the unfolded
degradation of ER-retained molecules is a consequence protein response. Cell 87:391–404
Farr GW, Scharl EC, Schumacher RJ Sondek S, Horwich ALof binding to prolyl hydroxidase is uncertain; it is likely
(1997) Chaperonin-mediated folding in the eukaryotic cyto-that at least two degradative pathways exist for these
sol proceeds through rounds of release of native and nonna-molecules (Lamande´ et al. 1995).
tive forms. Cell 89:927–937The ER is not the ﬁnal point of defense against missense
Finley D and Chau V (1991) Ubiquitination. Annu Rev Cellmutations for secreted proteins. Such proteins, collagens
Biol 7:25–69included, often form a complex array that involves multiple
Hammond C, Helenius A (1995) Quality control in the secre-
interactions with other proteins in the extracellular matrix tory pathway. Curr Opin Cell Biol 7:523–529
(ECM). Collagen-ﬁbril formation requires that the shape Hayes S, Dice J (1996) Roles of molecular chaperones in pro-
of themolecule bemaintained, and any change in the triple- tein degradation. J Cell Biol 132:255–258
helical domain interferes with aggregation of those mole- Hebert D, Foellmer B, Helenius A (1995a) Glucose trimming
cules into ﬁbrils. Hence, ﬁbril formation tends to exclude and reglucosylation determine glycoprotein association with
calnexing in the endoplasmic reticulum. Cell 81:425–433abnormally formed collagen triple helices, which appear
Hebert D, Simons J, Peterson J, Helenius A (1995b) Calnexin,to be degraded by ECM proteinases—another device to
calreticulin and BiP/Kar2p in protein folding. Cold Springsuppress expression of a potentially harmful protein. Ab-
Harbor Symp Quant Biol 60:405–415normal collagen molecules that evade this system and are
Hiller M, Finger A, Schweiger M, Wolf D (1996) ER degrada-integrated, even at low levels, can compromise mineraliza-
tion of a misfolded luminal protein by the cytosolic ubiqui-tion or other functions of the ﬁbril.
tin-proteasome pathway. Science 273:1725–1728Quality-control mechanisms, operating at multiple
Jensen T, Loo M, Pind S, Williams D, Goldberg A, Riordan J
sites within a cell and even in the extracellular space, (1995) Multiple proteolytic systems, including the protea-
remove abnormal proteins and prevent damage to cells some, contribute to CFTR processing. Cell 83:129–135
and tissues. Although they can be remarkably effective, Kim P, Arvan P (1995) Calnexin and BiP act as sequential
they may be less efﬁcient than the analogous process molecular chaperones during thyroglobulin folding in the
that targets truncated mRNA, in part because their sub- endoplasmic reticulum. J Cell Biol 128:29–38
strates have been ampliﬁed by translation and, in part, Kopito R (1997) ER quality control: the cytoplasmic connec-
tion. Cell 88:427–430because the substrates are more heterogeneous. The
Kuznetsov G, Bush K, Zhang P, Nigam S (1996) Perturbationsemerging hints of genetic diversity in this system reafﬁrm
in maturation of secretory proteins and their associationthe need for geneticists to understand the mechanisms
with endoplasmic reticulum chaperones in a cell cultureof gene regulation at all levels, because these provide
model for epithelial ischemia. Proc Natl Acad Sci USA 93:the biological context in which genetic variation plays
8584–8589out to create disease.
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